Track topics on Twitter Track topics that are important to you
Shares of Motus GI Holdings Inc. (MOTS) are down nearly 60% from their 52-week high of $10.66 recorded on July 9, 2018.
According to Motus, which is involved in improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, its Pure-Vu System is a US FDA-cleared medical device designated to help The pos...
Device firm Motus GI Holdings Inc. netted $12.6mm through a follow-on public offering of 5mm common shares at $2.70 each. The company will use the proceeds for R&D and commercialization activities, an...
Device firm Motus GI Holdings Inc. netted $14.4mm through a follow-on public offering of 5.75mm common shares (including full exercise of the overallotment) at $2.70 each. The company will use the pro...
The FDA has granted 510(k) clearance to Motus GI's Pure-Vu GEN2, a second-generation version of its Pure-Vu colonoscopy prep -More-
A follow-on offering of 5 million shares of common stock has been priced by Motus GI at $2.70 each in hopes of raising $13.5 -More-
Motus intends to present the full positive clinical results of the REDUCE study titled “Evaluation of Bowel Cleansing Efficacy in Hospitalized Patient Population Using the Pure-Vu System” at The ...
Motus GI Holdings Inc (NASDAQ:MOTS) CEO sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The medical technology company's flagship product is the Pure-Vu Sys...
Foundation plants shape the composition of local biotic communities and abiotic environments, but the impact of a plant's intraspecific variations on these processes is poorly understood. We examined ...
Amphipods of the genus Gammarus are a vital component of macrozoobenthic communities in European inland and coastal, marine and brackish waters of the Mediterranean and the Black Sea. Exceptional leve...
Semi-aquatic freshwater earthworms in the genus Glyphidrilus from Southeast Asia are characterized by both an extreme morphological crypsis among divergent phylogenetic lineages and a high morphologic...
The Motus GI Colon Cleansing device is intended to facilitate intra-procedural cleaning of a poorly prepared colon by irrigating the colon and evacuating the irrigation fluid and feces.
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient ...
We have published hundreds of Motus news stories on BioPortfolio along with dozens of Motus Clinical Trials and PubMed Articles about Motus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Motus Companies in our database. You can also find out about relevant Motus Drugs and Medications on this site too.